These differences are related to host characteristics (CD4+ cell counts), type of evaluated people (patients with active tuberculosis vs. people evaluated for LTBI), and setting (high-burden and resource-limited vs. low-burden and high-income settings), but are also due to differences in the criteria used for reporting data. The gene discussed is CD4; the disease is tuberculosis.